CU20110071A7 - COMPOUNDS AND COMPOSITIONS AS INHIBITORS OF KINASE PROTEINS - Google Patents
COMPOUNDS AND COMPOSITIONS AS INHIBITORS OF KINASE PROTEINSInfo
- Publication number
- CU20110071A7 CU20110071A7 CU20110071A CU20110071A CU20110071A7 CU 20110071 A7 CU20110071 A7 CU 20110071A7 CU 20110071 A CU20110071 A CU 20110071A CU 20110071 A CU20110071 A CU 20110071A CU 20110071 A7 CU20110071 A7 CU 20110071A7
- Authority
- CU
- Cuba
- Prior art keywords
- compounds
- kinase
- compositions
- inhibitors
- kinase proteins
- Prior art date
Links
- 108091000080 Phosphotransferase Proteins 0.000 title abstract 2
- 150000001875 compounds Chemical class 0.000 title abstract 2
- 102000020233 phosphotransferase Human genes 0.000 title abstract 2
- 239000003112 inhibitor Substances 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
- 102100033793 ALK tyrosine kinase receptor Human genes 0.000 abstract 2
- 101710168331 ALK tyrosine kinase receptor Proteins 0.000 abstract 2
- 102000016621 Focal Adhesion Protein-Tyrosine Kinases Human genes 0.000 abstract 2
- 108010067715 Focal Adhesion Protein-Tyrosine Kinases Proteins 0.000 abstract 2
- 108090000723 Insulin-Like Growth Factor I Proteins 0.000 abstract 2
- CZPWVGJYEJSRLH-UHFFFAOYSA-N Pyrimidine Chemical compound C1=CN=CN=C1 CZPWVGJYEJSRLH-UHFFFAOYSA-N 0.000 abstract 2
- 102000013275 Somatomedins Human genes 0.000 abstract 2
- 150000003222 pyridines Chemical class 0.000 abstract 2
- 102000007624 ZAP-70 Protein-Tyrosine Kinase Human genes 0.000 abstract 1
- 108010046882 ZAP-70 Protein-Tyrosine Kinase Proteins 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 230000005764 inhibitory process Effects 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
Landscapes
- Plural Heterocyclic Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
La invención proporciona novedosos derivados de pirimidina y piridina y composiciones farmacéuticas de los mismos, y procedimientos para usar tales compuestos. Por ejemplo, los derivados de pirimidina y piridina de la invención pueden usarse para tratar, mejorar o prevenir una afección que responde a la inhibición de actividad de la cinasa del linfoma anaplásico (ALK), cinasa de adhesión focal (FAK), cinasa 70 asociada a la cadena zeta (ZAP-70), factor de crecimiento similar a la insulina (IGF-1R), o una combinación de los mismos.The invention provides novel pyrimidine and pyridine derivatives and pharmaceutical compositions thereof, and methods for using such compounds. For example, the pyrimidine and pyridine derivatives of the invention can be used to treat, ameliorate or prevent a condition that responds to the inhibition of anaplastic lymphoma kinase (ALK) activity, focal adhesion kinase (FAK), associated kinase 70 to the zeta chain (ZAP-70), insulin-like growth factor (IGF-1R), or a combination thereof.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CU20110071A CU20110071A7 (en) | 2011-03-31 | 2011-03-31 | COMPOUNDS AND COMPOSITIONS AS INHIBITORS OF KINASE PROTEINS |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CU20110071A CU20110071A7 (en) | 2011-03-31 | 2011-03-31 | COMPOUNDS AND COMPOSITIONS AS INHIBITORS OF KINASE PROTEINS |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CU20110071A7 true CU20110071A7 (en) | 2011-12-28 |
Family
ID=45508753
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CU20110071A CU20110071A7 (en) | 2011-03-31 | 2011-03-31 | COMPOUNDS AND COMPOSITIONS AS INHIBITORS OF KINASE PROTEINS |
Country Status (1)
| Country | Link |
|---|---|
| CU (1) | CU20110071A7 (en) |
-
2011
- 2011-03-31 CU CU20110071A patent/CU20110071A7/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CU23829B1 (en) | COMPOUNDS AND COMPOSITIONS AS INHIBITORS OF KINASE PROTEINS | |
| SV2009003290A (en) | COMPOUNDS AND COMPOSITIONS AS PROTEIN CINASE INHIBITORS | |
| HN2010002733A (en) | COMPOUNDS AND COMPOSITIONS AS CINASE INHIBITORS | |
| CO2018002598A2 (en) | Compounds to modulate the expression of angiotensinogen, compositions containing them and processes for their production | |
| MX339937B (en) | Compounds and compositions as c-kit kinase inhibitors. | |
| PH12014500351B1 (en) | COMPOUNDS AND COMPOSITIONS AS c-KIT KINASE INHIBITORS | |
| MX2016015565A (en) | Certain protein kinase inhibitors. | |
| MD20170070A2 (en) | Quinazoline derivatives used to treat HIV | |
| GT201300174A (en) | INDOL COMPOUNDS OR ANALOGS OF THE SAME USEFUL FOR THE TREATMENT OF AGE-RELATED MACULAR DEGENERATION (DME) | |
| EA201792689A1 (en) | DERIVATIVES 2- (PYRAZOLOPIRIDIN-3-IL) Pyrimidine as inhibitors of JAK | |
| MX2014002486A (en) | Compounds and compositions as pdgfr kinase inhibitors. | |
| MX2017008520A (en) | Fused pyrimidine compounds for the treatment of hiv. | |
| MX2015012867A (en) | MULTISUSTITUTED AROMATIC COMPOUNDS AS INHIBITORS OF SERINA PROTEASA. | |
| UY34888A (en) | HEPATITIS C VIRUS INHIBITORS | |
| GT201400261A (en) | APPLICATION PCT FACE NATIONAL NOVEDOSAS N-PIRIDINIL AMIDAS CYCLES REPLACED AS QUINASE INHIBITORS | |
| MD4556B1 (en) | Compounds inhibiting the activity of catechol O-methyltransferase | |
| MX2017013886A (en) | Azabenzimidazoles and their use as ampa receptor modulators. | |
| EA201692313A1 (en) | Derivatives of indolysine as inhibitors of phosphosinositide-3-kinase | |
| MX356813B (en) | Hydantoin derivatives useful as kv3 inhibitors. | |
| PH12014501979A1 (en) | Fused bicyclic 2,4-diaminopyrimidine derivative as a dual alk and fak inhibitor | |
| MX2017013875A (en) | CERTAIN INHIBITORS OF PROTEIN QUINASA. | |
| MX374555B (en) | PYRIMIDINE DERIVATIVES AS BRUTON TYROSINE KINASE (BTK) INHIBITORS AND THEIR USES. | |
| EA201890364A1 (en) | COMPOUNDS SUITABLE FOR INHIBITING ROR-GAMMA-t | |
| CU20110071A7 (en) | COMPOUNDS AND COMPOSITIONS AS INHIBITORS OF KINASE PROTEINS | |
| CU20100259A7 (en) | PIRIMIDINE DERIVATIVES AS QUINASA INHIBITORS |